Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02562924 · ClinicalTrials.gov registry record · NA
The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery
A NA study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02562924 is a NA study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02562924, a NA study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will assess the effectiveness of MEDIHONEY® sinus rinses (alone or in combination with intranasal corticosteroids) vs. intranasal corticosteroid sinus rinses on mucosal healing and polyp recurrence in the post-operative period following functional endoscopic sinus surgery.
Interventions
- DRUG Prednisone
- DRUG Budesonide
- PROCEDURE Endoscopic sinus surgery
- DEVICE MEDIHONEY®
- DRUG Normal saline sinus rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02562924
The ClinicalTrials.gov registry entry for NCT02562924 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Prednisone is the first listed.
NCT02562924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02562924 about?
NCT02562924 is a clinical study titled "The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery". This study will assess the effectiveness of MEDIHONEY® sinus rinses (alone or in combination with intranasal corticosteroids) vs. intranasal corticosteroid sinus rinses on mucosal healing and polyp recurrence in the post-operative period following functional endoscopic sinus surgery.
What is the current status of trial NCT02562924?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-11. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02562924?
The interventions under investigation include: Prednisone (DRUG), Budesonide (DRUG), Endoscopic sinus surgery (PROCEDURE), MEDIHONEY® (DEVICE), Normal saline sinus rinse (DRUG).
Who is sponsoring clinical trial NCT02562924?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.